Neuberger Berman Group »

Apogee Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.5M 100k 75.48

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Alliancebernstein
Perceptive Advisors
Affinity Asset Advisors
Citadel Advisors
Jpmorgan Chase & Co

View all funds holding Apogee Therapeutics